trimethylcolchicinic acid methyl ether has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| JONSSON, U; LARSEN, W; LESSNER, H; LOEB, V | 1 |
| Hu, E; Jeffers, S; Ko, R; Koda, R; Muggia, F; Rosen, P; Scholtz, M | 1 |
3 other study(ies) available for trimethylcolchicinic acid methyl ether and Neoplasms
| Article | Year |
|---|---|
Preliminary clinical experience with trimethylcolchicinic acid methyl ether d-tartrate (TMCA) in various malignancies.
Topics: Antineoplastic Agents; Colchicine; Humans; Neoplasms; Tartrates | 1963 |
Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colchicine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Mouth Mucosa; Neoplasms; Remission Induction; Stomatitis; Thrombocytopenia | 1990 |
Gout medication analogue being tested against advanced solid tumors.
Topics: Colchicine; Drug Evaluation; Humans; Neoplasms | 1988 |